216 results on '"Ashkin, David"'
Search Results
2. Genotyped Cluster Investigations versus Standard Contact Tracing: Comparative Impact on Latent Tuberculosis Infection Cascade of Care in a Low-Incidence Region
3. Notes from the Field: Undiagnosed Tuberculosis During Pregnancy Resulting in a Neonatal Death — United States, 2021
4. Tuberculosis Regional Training and Medical Consultation Centers in the United States: Characteristics, outcomes, and quality of medical consultations, June 1, 2010 — May 31, 2014
5. Bacillus Calmette-Guerin Cases Reported to the National Tuberculosis Surveillance System, United States, 2004-2015
6. Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United States
7. Concomitant Treatment of TB and HCV in Coinfected Patients Using Serum Drug Concentration Monitoring
8. Undiagnosed Tuberculosis During Pregnancy Resulting in a Neonatal Death--United States, 2021
9. Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease.
10. 2354. Implementation of BPaL in the United States: Experience using a novel all-oral treatment regimen for rifampin-resistant or treatment-intolerant TB disease
11. Pretomanid in the Treatment of Patients with Tuberculosis in the United States
12. Concomitant Treatment of Tuberculosis and Hepatitis C Virus in Coinfected Patients Using Serum Drug Concentration Monitoring.
13. GENITOURINARY AND PULMONARY MULTIDRUG RESISTANT MYCOBACTERIUM TUBERCULOSIS INFECTION IN AN ASIAN ELEPHANT (ELEPHAS MAXIMUS)
14. Pharmacokinetic Evaluation of Rifabutin in Combination with Lopinavir-Ritonavir in Patients with HIV Infection and Active Tuberculosis
15. Effect of Rifabutin in Dolutegravir Dosing: A Case Series
16. 1400. Pretomanid in the Treatment of Patients with Tuberculosis in the United States: the Bedaquiline, Pretomanid and Linezolid (BPaL) Accelerated Monitoring (BAM) Project
17. Diagnosis of Latent Tuberculosis Infection in HIV-infected Pregnant Women.: “Baby Steps” toward Better Tuberculosis Control in Pregnancy
18. CHYLOUS ASCITES IN DISSEMINATED TB
19. Optimizing the Dose of Rifapentine to Treat Tuberculosis. Itʼs Elementary
20. Acute Lung Injury Outside of the ICU: Incidence in Respiratory Isolation on a General Ward
21. Non-tuberculous mycobacteria disease as a cause of hospitalization in HIV-infected subjects
22. Tuberculosis and Other Mycobacterial Diseases
23. Tuberculosis Therapy: “In Pursuit of Perfection”
24. AN UNSUSPECTING CASE OF CENTRAL NERVOUS SYSTEM TB
25. CLINICAL APPLICATION OF RAPID DETERMINANTS OF RESISTANCE IN PULMONARY TB
26. CLINICAL APPLICATION OF RAPID DETERMINANTS OF RESISTANCE IN EXTRAPULMONARY TB
27. Population Pharmacokinetics of Linezolid in Tuberculosis Patients: Dosing Regimen Simulation and Target Attainment Analysis
28. Ethionamide Population Pharmacokinetic Model and Target Attainment in Multidrug-Resistant Tuberculosis
29. Increased risk of Pneumocystis carinii and community-acquired pneumonia with tobacco use in HIV disease
30. List of Contributors
31. Mycobacterial Disease in Patients with HIV Infection
32. Feasibility of Shortening Respiratory Isolation with a Single Sputum Nucleic Acid Amplification Test
33. Coming Out of the Darkness
34. Acute lung injury outside of the ICU: incidence in respiratory isolation in a general ward
35. Discrepant Results Between Pyrazinamide Susceptibility Testing by the Reference BACTEC 460TB Method and pncA DNA Sequencing in Patients Infected With Multidrug-Resistant W-Beijing Mycobacterium tuberculosis Strains*
36. Consider Rifampin BUT Be Cautious
37. Urine Color Test to Monitor Isoniazid Compliance: "Pissin' in the Wind"?
38. Short-Course Rifamycin and Pyrazinamide Treatment for Latent Tuberculosis Infection in Patients With HIV Infection*: The 2-Year Experience of a Comprehensive Community-Based Program in Broward County, Florida
39. Who Dunnit?: The Changing Face of Tuberculosis Control Utilizing Restriction Fragment Length Polymorphism
40. Treatment Experience of Multidrug-Resistant Tuberculosis in Florida, 1994-1997*
41. Phthisiology at the Dawn of the New Century*: A Review of Tuberculosis and the Prospects for Its Elimination
42. Mesothelial Cells in Tuberculous Pleural Effusions of HIV-Infected Patients*
43. "Won't Get Fooled Again" (by Tuberculosis)
44. Use of rifabutin with protease inhibitors for HIV-infected tuberculosis patients.: 80E.
45. Tuberculosis following PD-1 blockade for cancer immunotherapy
46. Can we predict subtherapeutic antituberculosis serum drug levels in patients with tuberculosis?: 136E.
47. Paradoxical Worsening of Tuberculosis Following Antiretroviral Therapy in Patients with AIDS
48. Antituberculosis Drug–induced Hepatotoxicity: The Role of Hepatitis C Virus and the Human Immunodeficiency Virus
49. AN ATYPICAL PRESENTATION OF TB: A CASE REPORT
50. Multidrug-resistant tuberculosis in transplant recipients: Case report and review of the literature
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.